Isolation, Cryopreservation, and Immunophenotyping of Human Peripheral Blood Mononuclear Cells.

Isolation, Cryopreservation, and Immunophenotyping of Human Peripheral Blood Mononuclear Cells.
Curr Protoc Toxicol. 2017 Nov 08;74:18.20.1-18.20.16
Authors: Lauer FT, Denson JL, Burchiel SW
Abstract
This unit describes procedures for the isolation, cryopreservation, and thawing of human peripheral blood mononuclear cells (HPBMC) and analysis of cell surface markers (CSM) for immunophenotyping using polychromatic flow cytometry. This methodology can be used to ensure that cell integrity and phenotype stability are not altered through cryopreservation and extended storage. For this analysis, HPBMC were isolated from 7 healthy individuals, and 11-color flow cytometry was performed on freshly isolated samples as well as samples cryopreserved for short- and long-term periods. There is no significant difference in the percentage of cells expressing the CSM CD3, CD4, CD8, CD45RO, CD16, CD19, or CD56 between freshly isolated and cryopreserved HPBMC. Hence, cryopreservation of HPBMC does not influence the phenotype of distinct cellular subsets in isolated mononuclear cells. This protocol for HPBMC isolation, cryopreservation, and thawing of HPBMC is intended for long-term studies of large cohorts requiring sample shipment and subsequent batch analysis. © 2017 by John Wiley & Sons, Inc.
PMID: 29117436 [PubMed - in process]

Source: Current Protocols in Toxicology - November 9, 2017 Category: Toxicology Tags: Curr Protoc Toxicol Source Type: research